Find research datasets worth reusing

Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

ClinicalTrials.gov study NCT05264129. IPD Sharing: YES. Countries: 1. Publications: 0.

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

ClinicalTrials.gov study NCT03518034. IPD Sharing: NO. Countries: 2. Publications: 6.

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

ClinicalTrials.gov study NCT00423319. IPD Sharing: Not stated. Countries: 21. Publications: 3.

A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implemen

ClinicalTrials.gov study NCT02374450. IPD Sharing: NO. Countries: 3. Publications: 1.

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

ClinicalTrials.gov study NCT04270760. IPD Sharing: YES. Countries: 7. Publications: 6.

Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pi

ClinicalTrials.gov study NCT04903626. IPD Sharing: YES. Countries: 8. Publications: 1.

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

ClinicalTrials.gov study NCT00452530. IPD Sharing: Not stated. Countries: 27. Publications: 3.

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

ClinicalTrials.gov study NCT04255433. IPD Sharing: YES. Countries: 31. Publications: 3.

Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

ClinicalTrials.gov study NCT00371683. IPD Sharing: Not stated. Countries: 13. Publications: 2.

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov study NCT01144338. IPD Sharing: Not stated. Countries: 35. Publications: 18.

Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study

ClinicalTrials.gov study NCT01804257. IPD Sharing: Not stated. Countries: 1. Publications: 1.

A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

ClinicalTrials.gov study NCT05051904. IPD Sharing: NO. Countries: 1. Publications: 1.

A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

ClinicalTrials.gov study NCT01492361. IPD Sharing: NO. Countries: 11. Publications: 20.

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID

ClinicalTrials.gov study NCT04508023. IPD Sharing: YES. Countries: 1. Publications: 2.

Daily Wear Corneal Infiltrative Event Study

ClinicalTrials.gov study NCT00937105. IPD Sharing: Not stated. Countries: 1. Publications: 2.

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

ClinicalTrials.gov study NCT05563246. IPD Sharing: YES. Countries: 8. Publications: 3.

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo

ClinicalTrials.gov study NCT04927975. IPD Sharing: YES. Countries: 4. Publications: 2.

A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

ClinicalTrials.gov study NCT00320255. IPD Sharing: Not stated. Countries: 2. Publications: 2.

A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov study NCT05601882. IPD Sharing: YES. Countries: 29. Publications: 1.

Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair

ClinicalTrials.gov study NCT01920594. IPD Sharing: Not stated. Countries: 2. Publications: 1.